If you are searching for the best PRP injection, the most important thing to understand is that “PRP” is not one standardised treatment.

Two clinics can both advertise platelet-rich plasma (PRP) while delivering biologic products containing very different numbers of platelets, different cellular compositions and potentially very different volumes.

The difference can be substantial.

In some commonly used small-volume PRP systems, the total platelet dose may be measured in the low billions. High-volume concentrating systems can potentially deliver tens of billions of platelets.

So asking:

“How much does a PRP injection cost?”

is useful.

But asking:

“What am I actually receiving for that cost?”

is much more important.

For patients comparing PRP clinics on the Gold Coast, PRP treatment in Brisbane, high-dose PRP, regenerative medicine or image-guided PRP, there are several objective things that can be compared.

The first is the platelet dose.

The others are the diagnosis, biological composition, preparation quality, accuracy of delivery and whether the clinic actually measures its outcomes.

At MBR Health, we believe PRP should be approached as a measurable biological treatment rather than simply a procedure.

Diagnosis → Biology → Dose → Target → Precision Delivery → Follow-up

Learn more about the overall MBR Health PRP pathway here:
Platelet-Rich Plasma (PRP) at MBR Health

PRP is a label – not a dose

The term platelet-rich plasma tells you that a patient’s own blood has been processed to produce plasma containing an increased proportion of platelets. But it does not tell you how many platelets are ultimately injected. This problem has been recognised in the medical literature for more than a decade.

Mautner and colleagues argued that PRP research should report platelet concentration, injected volume, leukocyte content, red-cell content, activation and treatment frequency because preparations labelled “PRP” can be biologically very different.[1]

More recent research has increasingly moved toward another important measurement:

Total platelet dose.

That is the actual number of platelets delivered to the target.

And that is a much more meaningful number than simply saying: “This is PRP.”

Platelet concentration is not platelet dose

This distinction is extremely important.

A clinic may advertise:

“5× concentrated PRP”

“high-concentration PRP.”

Neither statement tells you the total number of platelets being injected.

The calculation is simple:

Platelet dose = platelet concentration × volume injected

For example, a small amount of highly concentrated PRP may actually contain fewer total platelets than a larger volume of moderately concentrated PRP.

This is why modern PRP research increasingly focuses on absolute platelet numbers, rather than simply reporting how many times above the patient’s baseline concentration a preparation has reached.

Everts and colleagues similarly argued that concentration or “fold increase” above baseline does not adequately describe the biological treatment. Their review proposed platelet dose – expressed as the actual number of platelets delivered – as a more useful PRP quality parameter.[2]

In other words:

“10× PRP” is a concentration claim.
“10 billion platelets delivered” is a dose.

Those are not the same thing – and you need to know DOSE.

For a more detailed explanation of this distinction, see:
Not All PRP Is the Same: Why Platelet Dose (High-Dose PRP) Matters

Does platelet dose actually change PRP outcomes?

Increasingly, the evidence suggests that it does – the published literature is currently strongest in knee osteoarthritis.

A systematic review by Berrigan and colleagues analysed 29 studies and 31 PRP treatment arms in knee osteoarthritis.

At six months, studies showing a statistically significant positive outcome delivered an average of approximately 5.5 billion platelets, compared with approximately 2.3 billion in studies that did not demonstrate a significant difference. A similar separation remained in studies reporting 12-month outcomes.[3]

A broader 2024 systematic review and meta-analysis examining PRP dose across musculoskeletal conditions reached a similar conclusion for knee osteoarthritis. The authors identified a potential dose-response relationship and reported that outcomes in knee OA appeared particularly favourable at doses exceeding 10 billion platelets, while emphasising that the dose-response relationship for other musculoskeletal conditions remains less certain.[4]

That qualification is important.

There is not one universal PRP dose for every body part.

A knee joint is not an Achilles tendon.
A tendon insertion is not an intervertebral disc.
A ligament is not a nerve.

The biological environment, available injection volume and disease process are different.

But the underlying concept is increasingly difficult to ignore:

Dose matters.

What does the 10-billion-platelet research actually show?

One of the most frequently cited studies is the prospective randomised study by Bansal and colleagues.

They randomised 150 patients with knee osteoarthritis to receive either hyaluronic acid or PRP formulated to deliver approximately 10 billion platelets.

At one year, the PRP group demonstrated sustained improvements in several clinical outcomes, and the authors concluded that an absolute platelet count around 10 billion was important to the sustained effect seen in their study.[5]

A 2025 review by Corsini and colleagues subsequently examined platelet-dose research across sports medicine and suggested that clinical outcomes appear more consistently favourable when individual injections exceed approximately 3.5–4 billion platelets, with cumulative doses around 10–12 billion platelets across treatment courses in the literature they reviewed.[6]

Again, these numbers should not be interpreted as a prescription for every tissue. The strongest dose-threshold evidence currently comes from knee osteoarthritis.

What the research does tell us is something more fundamental:

A PRP treatment should have a known dose.

If the dose is unknown, it becomes very difficult to compare treatments, reproduce successful research or understand why one PRP procedure performed better than another.

Why the amount of blood collected matters

There is a simple biological limitation that is sometimes overlooked:

You cannot concentrate platelets that were never collected.

Your blood contains a finite number of platelets.

The volume of blood collected therefore places an upper limit on the number of platelets available for a PRP preparation.

A system processing 10 mL of whole blood starts with a substantially smaller platelet pool than a system processing 120 mL. No centrifuge can manufacture additional platelets. It can only recover and concentrate those already present.

This is why a seemingly mundane question can tell you a great deal about a PRP treatment:

“How much blood are you taking?”

MBR Health uses a high-volume closed preparation system for its high-dose PRP pathway. Its existing PRP information explains that higher-dose pathways generally require a larger blood draw than simplified tube-based systems. MBR Health

How different can PRP systems actually be?

Potentially, by an order of magnitude.

MBR Health has previously published a transparent comparison based on blood volume, typical baseline platelet counts and published or manufacturer-stated recovery rates.

In that modelling, a 120 mL EmCyte double-spin system produced an estimated theoretical platelet pool of approximately 13.5–29.7 billion platelets, depending on the patient’s baseline platelet count.

A 10 mL RegenLab system was estimated at approximately 1.0–2.2 billion platelets under the assumptions used.[7]

That does not mean every patient using the larger system receives exactly those numbers, and it does not by itself prove that one commercial kit produces a better clinical outcome.

They are theoretical dose estimates.

The actual dose depends on the patient’s baseline platelet count, recovery efficiency, preparation technique, final PRP concentration and volume ultimately injected.

But the comparison demonstrates an important principle:

Two treatments carrying exactly the same name — “PRP injection” — can have dramatically different biological dose ceilings.

MBR Health’s published comparison explicitly states that these numbers are estimates and that the true final injectate should ideally be measured. MBR Health

That is transparency. And transparency is important when patients are trying to compare PRP treatments.

Does that mean more platelets are better?

Increasingly, the evidence suggests yes – provided the dose can be delivered safely and appropriately to the target tissue.

The emerging direction of PRP research is that higher total platelet dose is associated with better and more durable outcomes, particularly in knee osteoarthritis, where the dose-response evidence is currently strongest. Systematic reviews have found that studies producing better clinical outcomes generally delivered substantially higher platelet doses than studies with negative or less convincing results, and more recent reviews increasingly argue that total platelet dose should be considered a central measure of PRP treatment quality.[3,4]

At MBR Health, our practical interpretation is therefore:

Deliver the highest biologically useful platelet dose that can reasonably and safely be accommodated by the tissue being treated.

But platelet dose and injection volume are not the same thing.

A tendon tear, for example, cannot simply be filled with progressively larger volumes of fluid. Excessive volume may increase post-procedural pain and swelling and, in a structurally compromised tendon, care must be taken not to mechanically distend the tissue or unnecessarily separate existing fibres. The objective is therefore to increase the number of platelets delivered, not simply the amount of fluid injected.

This is one reason high-efficiency PRP preparation matters. Ideally, the treatment should deliver a very large number of platelets within a volume appropriate to the anatomy.

The same principle applies elsewhere. A large joint can generally accommodate more volume than a small tendon insertion. An intradiscal injection has very different volume constraints again. The maximum practical biological dose therefore has to be matched to the size, structure and pathology of the treatment target.

There is another consideration: PRP is more than platelets alone.

The plasma itself is biologically active and contains proteins, growth factors and signalling molecules that may contribute to the overall biological environment. Reviews of PRP bioformulation emphasise that therapeutic activity depends not only on platelet number but also on the broader cellular and plasma composition of the preparation.[2]

This means that simply attempting to produce the smallest possible volume of extremely concentrated platelets is not necessarily the ideal objective either. There may be value in retaining an appropriate plasma component while still delivering a high total platelet dose.

Leukocyte composition, neutrophils, red-cell contamination and activation also matter. Mautner and colleagues specifically proposed that platelet concentration, injected volume, leukocytes, red cells and activation should all be reported when describing PRP.[1] Mautner et al 2015 Corsini and colleagues similarly emphasise platelet dose, leukocyte composition, red-cell contamination and preparation strategy as important determinants of PRP performance. corsini 2025

So rather than asking:

“Can you make the PRP as concentrated as possible?”

we think the better question is:

“What is the highest appropriate platelet dose that can be safely delivered to this particular injury, in a biologically useful volume and formulation?”

That is an important distinction.

More platelets may be better. More volume is not necessarily better.

The aim is to maximise the biological dose while respecting the anatomy, avoiding unnecessary pressure or tissue distension, managing the inflammatory response and preserving the potentially useful biological components of the plasma.

High-dose PRP is not the same as high-concentration PRP

This is worth repeating because the terms are frequently confused.

High concentration describes how tightly platelets are concentrated within a volume. High dose describes how many total platelets are ultimately delivered.

Imagine a clinic produces a highly concentrated 1 mL PRP preparation. Another clinic produces a moderately lower concentration but injects 8 mL. The second treatment could contain many more total platelets.

This is why patients comparing high-dose PRP on the Gold Coast should ask for the total platelet number rather than relying on labels such as “5×”, “7×”, “10×”, “premium PRP” or “super PRP”.

Those phrases are not doses.

The best PRP is not simply the strongest PRP

There is another major problem with comparing PRP purely by platelet numbers.

A large dose delivered to the wrong structure is still the wrong treatment.

PRP should not be used as a substitute for diagnosis.

Knee pain may arise from osteoarthritis, meniscal disease, a ligament injury, an insufficiency fracture, patellofemoral disease or referred pain.

Shoulder pain may arise from a rotator cuff tendon, bursa, joint, labrum, acromioclavicular joint or cervical nerve.

Back pain may arise from a disc, facet joint, nerve root, sacroiliac joint or another structure entirely.

The biologic may be excellent.

But if the diagnosis is wrong, the treatment is unlikely to be optimised.

This is why MBR Health’s PRP service begins with diagnosis rather than with an injection. The clinic’s current PRP pathway describes its approach as “PRP is only as good as the diagnosis, the dose and the delivery.” MBR Health

Explore MBR Health’s PRP treatment pathway

Accuracy of delivery matters too

PRP is not a tablet.

It does not circulate through the body looking for an injured tendon or ligament.

It has to be physically placed into the intended biological environment.

That may be:

a joint,
a tendon tear,
a ligament,
a tendon insertion,
a disc,
a facet joint,
a nerve-adjacent plane,
or another precisely defined target.

The choice of imaging guidance should depend on the anatomy.

MBR Health uses ultrasound, CT and other imaging strategies according to the structure being treated, rather than treating every procedure with the same guidance technique. Its current PRP pathway specifically describes image-guided delivery as part of the treatment model. MBR Health

For complex spinal procedures, this becomes particularly important.

Our separate guide to spinal PRP explains why specialist diagnosis, CT guidance and documented needle placement matter when treating deep spinal anatomy.

Internal link here to: Who Should Perform a Spinal PRP Injection? Why Diagnosis, Spinal Training and Image Guidance Matter.

What about platelet quality?

Platelet number is not everything. PRP is prepared from the patient’s own blood – as Dr. Zane Sherif says:

“You are the pharmacy for this medication”

That means the patient is effectively the source material for the treatment.

Baseline platelet count, medications, smoking, systemic health, inflammation and the way the blood is collected and processed can all influence the final preparation. Processing variables matter as well.

The anticoagulant used, centrifugation technique, temperature, platelet activation, handling time and contamination with unwanted cellular fractions can potentially change the final biologic.

This is why serious PRP practice increasingly looks less like:

draw blood → spin tube → inject

and more like:

diagnose → select biologic → collect → process → quantify → deliver → document → follow up.

If your previous PRP treatment did not work, MBR Health has a separate detailed guide explaining why dose, diagnosis, preparation and delivery may all contribute.

Why PRP May Not Have Worked

What should I ask when comparing PRP clinics?

Patients searching for the best PRP clinic on the Gold Coast should be able to ask objective questions rather than relying on adjectives.

The most useful questions are:

How much blood will you collect? This determines the size of the platelet pool available for concentration.
What is the expected or measured platelet concentration? The actual kit they are using will determine this.
What volume of PRP will actually be injected? Sometimes this is dictated by anatomy, sometimes by the methodology adopted.
What is the total platelet dose in billions of platelets? They should initially estimate this from the whole blood draw and then confirm by either on-site platelet counter or by sending a sample away.
What is the cellular formulation — including leukocytes and red-cell contamination? This may be dependent on the kit used as well as the methodology chosen by the provider.
How have you confirmed that PRP is appropriate for my diagnosis? The reporting radiologist from your diagnosis should have experience in regenerative treatments.
Will the procedure be image guided, and which imaging modality is best for my target? At MBR Health we typically perform deep joint and spinal procedures under CT.
Will the final needle placement or treatment delivery be documented where appropriate? The answer should ALWAYS be YES.
How will my outcome be followed? You should experience therapeutic results from an orthopaedic injection within approximately 3-5 weeks with the full extent of pain relief realised at about 3 months but may extend up to a year.
Does the clinic measure, audit or publish its clinical outcomes? MBR Health is achieving quantitative outcomes previously not observed and we publish these results on our publications page.

If the discussion never moves beyond:

“We use PRP.”

you still know remarkably little about the treatment.

How does MBR Health approach PRP differently?

At MBR Health on the Gold Coast, our regenerative medicine program has been built around a simple principle:

If a biological treatment can be measured, it should be measured.

Our approach combines specialist diagnostic imaging, high-volume PRP preparation, image-guided treatment, protocol development and objective follow-up.

The objective is not simply to inject more platelets.

It is to understand:

what is injured

→ whether PRP is biologically appropriate

→ what platelet dose is being delivered

→ what formulation is appropriate

→ where it needs to be delivered

→ whether it reached the target

→ and what happened afterwards.

MBR Health also conducts investigator-initiated research into PRP and other regenerative therapies, with a focus on diagnosis, precision delivery, protocol optimisation and objective outcome measurement. MBR Health

Explore Regenerative Medicine Research at MBR Health

From clinical outcomes to peer-reviewed research

Regenerative medicine remains an evolving field.

That means promising clinical results should not simply become marketing claims.

They should become questions.

They should be documented, investigated and — where appropriate — published so that other clinicians can scrutinise and reproduce them.

MBR Health’s research program has published peer-reviewed work involving MRI-documented ACL re-continuity, CT-guided intradiscal PRP delivery, image-guided hip PRP delivery and other regenerative applications. MBR Health

At MBR Health, our approach is therefore to diagnose accurately, quantify the biology, deliver it precisely, document the procedure and follow patients to determine outcomes.

When clinical outcomes appear particularly promising, we believe the next step is not simply to advertise them.

It is to publish them.

View MBR Health’s peer-reviewed publications

So what is the best PRP injection?

There is no single PRP preparation that can credibly be called the best treatment for every patient and every condition.

But there are objective markers of a high-quality PRP pathway.

The diagnosis should be accurate.
The platelet dose should be known.
The preparation should be biologically appropriate for the tissue.
The injection should reach the intended target.
The procedure should be documented.
And the outcome should be followed.

For knee osteoarthritis specifically, current research increasingly suggests that higher platelet doses — particularly in the several-billion to approximately 10-billion-plus range — are associated with more consistent outcomes than very low-dose preparations, although the exact optimal dose remains condition-specific.[3–6]

So when comparing PRP providers, don’t simply ask:

“Do you offer PRP?”

Ask:

“What exactly are you injecting, how much are you delivering, why are you putting it there — and how will you know whether it worked?”

PRP should be measured by what is delivered — not by what it is called.

Frequently Asked Questions

What is the strongest PRP?

“Strongest” is not a well-defined medical term. A more meaningful measure is total platelet dose: the number of platelets actually delivered to the target. High concentration does not necessarily equal high dose because injected volume also matters.

How many platelets should a PRP injection contain?

It depends on the condition. Knee osteoarthritis currently has some of the clearest dose-response evidence, with several studies suggesting improved outcomes at higher platelet doses and some literature identifying approximately 10 billion platelets as an important threshold. Other tissues may require different doses, and the evidence remains less certain.[4–6]

Is 10 billion platelets better than 2 billion?

For knee osteoarthritis, available evidence suggests higher-dose preparations are associated with more consistent clinical outcomes than low-dose preparations. That does not mean 10 billion is automatically superior for every tendon, ligament, nerve or spinal indication. s12178-024-09922-x

Why does a larger blood draw matter?

More whole blood provides a larger starting pool of platelets. A small-volume tube system cannot recover platelets that were never collected. However, final dose also depends on the patient’s baseline platelet count, platelet recovery and preparation process.

Can I ask my PRP clinic how many platelets I am receiving?

Yes. It is a reasonable question. The clinic should ideally be able to explain the expected or measured platelet concentration, volume injected and therefore the approximate total platelet dose.

Is high-dose PRP always better?

No. The appropriate dose and cellular composition depend on the tissue and condition being treated. Biological dose is one component of treatment quality; diagnosis and precise delivery are equally important.

Does MBR Health use high-dose PRP?

MBR Health uses a high-volume closed PRP preparation pathway designed to allow clinically meaningful platelet doses, with treatment selected according to diagnosis, anatomy and biological objective. The clinic’s research program also focuses on quantification, precision delivery and objective follow-up. MBR Health

References

1. Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM&R. 2015;7(4 Suppl):S53–S59. doi:10.1016/j.pmrj.2015.02.005. Mautner et al 2015

2. Everts PA, Lana JF, Onishi K, Buford D, Peng J, Mahmood A, et al. Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures. Biomedicines. 2023;11:1922. doi:10.3390/biomedicines11071922. biomedicines-11-01922-v3

3. Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2025;41(3):809–817. doi:10.1016/j.arthro.2024.03.018. Berrign et al 2025

4. Berrigan W, Tao F, Kopcow J, Park AL, Allen I, Tahir P, et al. The Effect of Platelet Dose on Outcomes after Platelet Rich Plasma Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis. Curr Rev Musculoskelet Med. 2024;17:570–588. doi:10.1007/s12178-024-09922-x. s12178-024-09922-x

5. Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Sci Rep. 2021;11:3971. doi:10.1038/s41598-021-83025-2. bansal et al 2025

6. Corsini A, Perticarini L, Palermi S, Bettinsoli P, Marchini A. Re-Evaluating Platelet-Rich Plasma Dosing Strategies in Sports Medicine: The Role of the “10 Billion Platelet Dose” in Optimizing Therapeutic Outcomes. J Clin Med. 2025;14:2714. doi:10.3390/jcm14082714. corsini 2025

7. MBR Health. Not All PRP Is the Same: Why Platelet Dose (High-Dose PRP) Matters. 2026. The published comparison uses whole-blood volume, assumed baseline platelet counts and published/manufacturer recovery figures to estimate theoretical dose ranges and explicitly recommends measurement of the final injectate. MBR Health

Best SEO setup

SEO title:
Best PRP Gold Coast? How to Compare PRP Dose & Quality | MBR Health

I prefer this to “What Is the Best PRP Injection?” as the SEO title because it captures the high-value local query while phrasing “best” as the patient’s question rather than an unqualified superiority claim.